Loading…

Gene delivery in the cornea: in vitro & ex vivo evaluation of solid lipid nanoparticle-based vectors

Inflammation is a process that underlies sight-threatening ocular surface diseases, and gene supplementation with the plasmid that encodes for p-IL10 will allow the sustained de novo synthesis of the cytokine to occur in corneal cells, and provide a long-term anti-inflammatory effect. This work desc...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine (London, England) England), 2018-08, Vol.13 (15), p.1847-1854
Main Authors: Vicente-Pascual, Mónica, Albano, Andrea, Solinís, María Á, Serpe, Loredana, Rodríguez-Gascón, Alicia, Foglietta, Federica, Muntoni, Elisabetta, Torrecilla, Josune, Pozo-Rodríguez, Ana Del, Battaglia, Luigi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inflammation is a process that underlies sight-threatening ocular surface diseases, and gene supplementation with the plasmid that encodes for p-IL10 will allow the sustained de novo synthesis of the cytokine to occur in corneal cells, and provide a long-term anti-inflammatory effect. This work describes the development of solid lipid nanoparticle systems for the delivery of p-IL10 to transfect the cornea. In vitro, vectors showed suitable features as nonviral vectors (size, ζ-potential, DNA binding, protection and release), and they were able to enter and transfect human corneal epithelial cells. Ex vivo, the vectors were found to transfect the epithelium, the stroma and the endothelium in rabbit corneal explants. Distribution of gene expression within the cell layers of the cornea depended on the composition of the four vectors evaluated. Solid lipid nanoparticle-based vectors are promising gene delivery systems for corneal diseases, including inflammation.
ISSN:1743-5889
1748-6963
DOI:10.2217/nnm-2018-0112